Citation: | XIA Kun, ZHANG Yong, ZHOU Dan. The correlation between serum KLF2 and S1P1 levels and coronary artery injury in children with Kawasaki disease[J]. Chinese Journal of General Practice, 2024, 22(10): 1714-1717. doi: 10.16766/j.cnki.issn.1674-4152.003718 |
[1] |
闵丽, 王晋, 董湘玉. 人软骨糖蛋白-39、N端脑钠肽前体在川崎病患儿冠状动脉损伤中的应用价值[J]. 实用临床医药杂志, 2024, 28(3): 1-5.
MIN L, WANG J, DONG X Y. Value of human cartilage glycoprotein-39 and N-terminal prohormone of brain natriuretic peptide in coronary artery injury in children with Kawasaki disease[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 1-5.
|
[2] |
PIRAM M, BURNS J C. Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology[J]. Clin Exp Dermatol, 2021, 46(3): 503-509. doi: 10.1111/ced.14558
|
[3] |
BURNS J C, ROBERTS S C, TREMOULET A H, et al. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial[J]. Lancet Child Adolesc Health, 2021, 5(12): 852-861. doi: 10.1016/S2352-4642(21)00270-4
|
[4] |
王一铮, 王鹤, 蔡飞, 等. 血府逐瘀胶囊含药血清对人微血管内皮细胞KLF2表达的影响[J]. 中医杂志, 2021, 62(15): 1356-1361.
WANG Y Z, WANG H, CAI F, et al. Effect of Xuefu Zhuyu Capsule-Containing Serum on the Expression of KLF2 in Human Microvascular Endothelial Cells[J]. Journal of Traditional Chinese Medicine, 2021, 62(15): 1356-1361.
|
[5] |
金芙蓉, 潘一红, 瞿向东. 小檗碱对卵巢癌SKOV3细胞S1P/S1PR1通路调控作用及对血管生成的影响[J]. 中国妇幼保健, 2023, 38(4): 712-716.
JIN F R, PAN Y H, QU X D. Effects of berberine on the regulation of S1P/S1PR1 pathway and angiogenesis in ovarian cancer SKOV3 cells[J]. Maternal & Child Health Care of China, 2023, 38(4): 712-716.
|
[6] |
LIN C M, WANG B W, PAN C M, et al. Chrysin boosts KLF2 expression through suppression of endothelial cell-derived exosomal microRNA-92a in the model of atheroprotection[J]. Eur J Nutr, 2021, 60(8): 4345-4355. doi: 10.1007/s00394-021-02593-1
|
[7] |
TAKAHASHI H, NAKAGAWA K, YAMADA H, et al. Time course of collateral vessel formation after retinal vein occlusion visualized by OCTA and elucidation of factors in their formation[J]. Heliyon, 2021, 7(1): 1-13.
|
[8] |
黄铮, 吴平生. 美国心脏病学会(AHA)川崎病诊断指南[J]. 岭南心血管病杂志, 2003, 9(4): 301-304.
HUANG Z, WU P S. American Heart Association (AHA) Guidelines for Kawasaki Disease diagnosis[J]. South China Journal of Cardiovascular Diseases, 2003, 9(4): 301-304.
|
[9] |
DANIELS L B, GORDON J B, BURNS J C. Kawasaki disease: late cardiovascular sequelae[J]. Curr Opin Cardiol, 2012, 27(6): 572-577. doi: 10.1097/HCO.0b013e3283588f06
|
[10] |
陈玉萍, 张兰. 不同炎性指标检测在川崎病患儿诊断中的价值[J]. 中华全科医学, 2020, 18(3): 362-364.
CHEN Y P, ZHANG L. The value of different inflammatory indicators in children with Kawasaki disease[J]. Chinese Journal of General Practice, 2020, 18(3): 362-364.
|
[11] |
王萌, 张瑄, 邢淑华, 等. 血清趋化素水平与川崎病患儿急性期冠状动脉损害的相关研究[J]. 中国临床医生杂志, 2023, 51(11): 1361-1364.
WANG M, ZHANG X, XING S H, et al. Relationship between serum chemokine level and coronary artery damage in children with Kawasaki disease[J]. Chinese Journal of Clinicians, 2023, 51(11): 1361-1364.
|
[12] |
BORDEA M A, COSTACHE C, GRAMA A, et al. Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome[J]. Physiol Res, 2022, 71(1): 17-27.
|
[13] |
CHEN C, CHEN J, TAO X, et al. Activation of GPR30 with G1 inhibits oscillatory shear stress-induced adhesion of THP-1 monocytes to HAECs by increasing KLF2[J]. Aging (Albany NY), 2021, 13(8): 11942-11953.
|
[14] |
SU T, YANG Y, LAI S, et al. Single-Cell Transcriptomics Reveals Zone-Specific Alterations of Liver Sinusoidal Endothelial Cells in Cirrhosis[J]. Cell Mol Gastroenterol Hepatol, 2021, 11(4): 1139-1161.
|
[15] |
JIANG Y, SHEN Q. IRF2BP2 prevents ox-LDL-induced inflammation and EMT in endothelial cells via regulation of KLF2[J]. Exp Ther Med, 2021, 21(5): 481-494.
|
[16] |
LI H, WANG Y, LIU J, et al. Endothelial Klf2-Foxp1-TGFβ signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling[J]. Theranostics, 2021, 11(4): 1609-1625.
|
[17] |
陈亮, 柏洁, 郑扣龙. KLF2在急性冠脉综合征中的作用研究[J]. 南京医科大学学报(自然科学版), 2022, 42(3): 345-351.
CHEN L, BAI J, ZHENG K L. The role of KLF2 in acute coronary syndrome[J]. Journal of Nanjing Medical University, 2022, 42(3): 345-351.
|
[18] |
NITZSCHE A, POITTEVIN M, BENARAB A, et al. Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic Stroke[J]. Circ Res, 2021, 128(3): 363-382.
|
[19] |
BAEYENS A, BRACERO S, CHALUVADI VS, et al. Monocyte-derived S1P in the lymph node regulates immune responses[J]. Nature, 2021, 592(7853): 290-295.
|
[20] |
ALSHAIKH R A, RYAN K B, WAEBER C. Sphingosine 1-phosphate, a potential target in neovascular retinal disease[J]. Br J Ophthalmol, 2022, 106(9): 1187-1195.
|
[21] |
任宏强, 刘益均, 罗贵全, 等. 1-磷酸鞘氨醇1型受体促进小鼠颈动脉损伤后血管内膜增生[J]. 第三军医大学学报, 2021, 43(3): 202-210.
REN H Q, LIU Y J, LUO G Q, et al. Sphingosine-l-phosphate type 1 receptor aggravates neointimal hyperplasia after carotid artery injury in mice[J]. Journal of Army Medical University, 2021, 43(3): 202-210.
|
[22] |
钱翠平, 黄晓碧, 赵胜, 等. 儿童川崎病冠状动脉损伤危险因素logistic回归分析[J]. 安徽医科大学学报, 2023, 58(3): 490-494.
QIAN C P, HUANG X B, ZHAO S, et al. Regression analysis of risk factors related to coronary artery lesion in children with Kawasaki disease[J]. Acta Universitatis Medicinalis Anhui, 2023, 58(3): 490-494.
|
[23] |
胡红梅, 邱云, 谢帅, 等. 川崎病并发冠状动脉损伤的危险因素及预测因子研究[J]. 保健医学研究与实践, 2023, 20(8): 71-75.
HU H M, QIU Y, XIE S, et al. Risk factors and predictors of coronary artery lesion in children with Kawasaki disease[J]. Health Medicine Research and Practice, 2023, 20(8): 71-75.
|
[24] |
孙书丽, 何鑫. 川崎病患儿血清生长分化因子-15趋化素及正五聚蛋白3水平与炎症细胞因子冠状动脉损伤的相关性[J]. 中国妇幼保健, 2021, 36(15): 3497-3501.
SUN S L, HE X. Study on the relationship between serum levels of growth differentiation factor-15 and chemokine and pentapmerin 3 and inflammatory factors and coronary artery in-jury in Kawasaki disease children[J]. Maternal & Child Health Care of China, 2021, 36(15): 3497-3501.
|
[25] |
CHEN L, SHANGGUAN Z, DONG Z, et al. NFIL3 aggravates human coronary artery endothelial cell injury by promoting ITGAM transcription in Kawasaki disease[J]. Hematology, 2023, 28(1): 227-239.
|